Colin Shannon, President & CEO at PRA Health Sciences, Inc. (PRAH), sold 16,252 shares at $167.39 ($2.7M) on 2021-06-16, disclosed to the SEC on 2021-06-30.
Open-market sale of $2.7M PRAH by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $166.42 | 7,132 | $1.2M | 43.8% |
| 2 | $166.42 | 7,132 | $1.2M | 43.8% |
| 3 | $167.39 | 564 | $94K | 3.5% |
| 4 | $167.39 | 564 | $94K | 3.5% |
| 5 | $168.13 | 430 | $72K | 2.7% |
| 6 | $168.13 | 430 |
| $72K |
| 2.7% |
| Total | $166.58 avg | 16,252 | $2.7M | 100% |
| Filing → |
| PRAH | SELL | 2021-06-03 | $2.2M | — | Filing → |
| PRAH | SELL | 2020-08-17 | $1.2M | — | Filing → |
| PRAH | SELL | 2017-08-16 | $59.9M | — | Filing → |